Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01700452 · ClinicalTrials.gov registry record
Diagnostic Study for Lung Cancer Detection Test
A clinical trial of Lung Cancer, sponsored by Bioview.
- Completed
- Registry status
- 173
- Enrollment target
- 6
- Study locations
NCT01700452: Completed study of Lung Cancer, sponsored by Bioview.
NCT01700452 is a study of Lung Cancer that has completed, run by Bioview. The registered enrollment target is 173 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (81% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01700452, a study of Lung Cancer, has completed, sponsored by Bioview.
- COMPLETED
- Registry status
- 173 participants
- Enrollment target
- 6
- Study locations
Study Summary
Early detection of lung cancer and early removal of the cancer nodules facilitates the diagnosis and treatment. However, not all nodules are malignant. Currently the standard method to diagnose lung cancer is to remove any suspicious nodules from the lung in a surgical procedure. This study is being conducted to evaluate the performance of a laboratory test to detect changes in lung cells that might be an early indicator of lung cancer. The test uses mucus (sputum) which is collected in a non-invasive method. This study will compare the results of the lung biopsy with the laboratory test to determine if the test can detect cancer or the lack of cancer. The laboratory test will not be shared with the treating physician or the patient as the current standard for lung cancer diagnosis is a biopsy. Approximately 330 patients will be enrolled in the study. There is one visit involved and includes the collection of a sputum specimen by coughing into a cup. The medical records of patients who are negative for cancer by biopsy will be reviewed for 2 years to detect any changes in diagnosis.
Conditions Studied
Study Locations (6)
Other
- Kaplan Medical Center - Rehovot
- Tel-Aviv Sourasky Medical Center - Tel Aviv
- Sheba Medical Center Thoracic Cancer Research and Detection Center - Tel Litwinsky
California
- VA Greater Los Angeles Health System - Los Angeles
Maryland
- Frederick Memorial Hospital, Regional Cancer Center - Frederick
Pennsylvania
- St. Luke's Hospital - Bethlehem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01700452
The ClinicalTrials.gov registry entry for NCT01700452 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (81% lower). The listed sponsor is Bioview, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01700452 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Other, California, Maryland.
Frequently Asked Questions
What is clinical trial NCT01700452 about?
NCT01700452 is a clinical study titled "Diagnostic Study for Lung Cancer Detection Test". Early detection of lung cancer and early removal of the cancer nodules facilitates the diagnosis and treatment. However, not all nodules are malignant. Currently the standard method to diagnose lung cancer is to remove any suspicious nodules from the lung in a surgical procedure. This study is bein...
What is the current status of trial NCT01700452?
This trial is currently completed. The enrollment target is 173 participants. The study started on 2012-04. Estimated completion is 2016-04.
What conditions does trial NCT01700452 study?
This clinical trial studies the following conditions: Lung Cancer.
Who is sponsoring clinical trial NCT01700452?
This trial is sponsored by Bioview, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01700452 being conducted?
This trial has 6 study locations across California, Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.